Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20988 | 437 | 29.6 | 55% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
489 | 3 | CISPLATIN//STABILITY CONSTANTS//JOURNAL OF INORGANIC BIOCHEMISTRY | 23107 |
1065 | 2 | CISPLATIN//NEPHROTOXICITY//PLATINUMII COMPLEXES | 9996 |
20988 | 1 | LEHRSTUHL PHARMAZEUT CHEM 2//GRP RECH ONCOL ENDOCRINOL MOL//PORPHYRIN PLATINUM CONJUGATES | 437 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LEHRSTUHL PHARMAZEUT CHEM 2 | address | 773987 | 3% | 92% | 12 |
2 | GRP RECH ONCOL ENDOCRINOL MOL | address | 343989 | 2% | 62% | 8 |
3 | PORPHYRIN PLATINUM CONJUGATES | authKW | 279496 | 1% | 100% | 4 |
4 | ESTROGEN RECEPTOR AFFINITY | authKW | 223595 | 1% | 80% | 4 |
5 | ESTROGEN RECEPTOR TARGETED DELIVERY OF PHOTOTOXINS | authKW | 209622 | 1% | 100% | 3 |
6 | ZINDOXIFENE | authKW | 209622 | 1% | 100% | 3 |
7 | 1 2 BIS2 6 DIFLUORO 3 HYDROXYPHENYLETHYLENEDIAMINEPLATINUMII COMPLEXES | authKW | 139748 | 0% | 100% | 2 |
8 | LEHRSTUHL PHARMACEUT CHEM 2 | address | 139748 | 0% | 100% | 2 |
9 | MESO 1 2 BIS2 6 DICHLORO 4 HYDROXYPHENYLETHYLENEDIAMINEDICHLOROPLATINUMII | authKW | 139748 | 0% | 100% | 2 |
10 | MXT M 3 2 BREAST CANCER | authKW | 139748 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 8683 | 42% | 0% | 182 |
2 | Chemistry, Multidisciplinary | 713 | 28% | 0% | 121 |
3 | Pharmacology & Pharmacy | 643 | 24% | 0% | 105 |
4 | Chemistry, Inorganic & Nuclear | 560 | 14% | 0% | 59 |
5 | Oncology | 270 | 15% | 0% | 64 |
6 | Chemistry, Organic | 257 | 12% | 0% | 54 |
7 | Biochemistry & Molecular Biology | 54 | 14% | 0% | 60 |
8 | Endocrinology & Metabolism | 42 | 5% | 0% | 22 |
9 | Chemistry, Analytical | 12 | 4% | 0% | 17 |
10 | Biochemical Research Methods | 4 | 2% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LEHRSTUHL PHARMAZEUT CHEM 2 | 773987 | 3% | 92% | 12 |
2 | GRP RECH ONCOL ENDOCRINOL MOL | 343989 | 2% | 62% | 8 |
3 | LEHRSTUHL PHARMACEUT CHEM 2 | 139748 | 0% | 100% | 2 |
4 | SERV MED CANCEROL MAMMAIRE | 139748 | 0% | 100% | 2 |
5 | GRP RECH BIOPATHOL CELLULAI MOL | 101630 | 1% | 36% | 4 |
6 | DIPATIMENTO SCI CHIM FIS MATEMAT | 69874 | 0% | 100% | 1 |
7 | GRP RECH BIOPHATOL CELLULAI MOL | 69874 | 0% | 100% | 1 |
8 | NPO ORGAN INTERMEDIATES DYES | 69874 | 0% | 100% | 1 |
9 | PHARMAZEUT CHEM 2 | 69874 | 0% | 100% | 1 |
10 | PHARMAZEUT MED CHEM 2 | 69874 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARCHIV DER PHARMAZIE | 93950 | 17% | 2% | 76 |
2 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 12216 | 7% | 1% | 29 |
3 | JOURNAL OF MEDICINAL CHEMISTRY | 6575 | 10% | 0% | 45 |
4 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2687 | 4% | 0% | 19 |
5 | INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY | 1962 | 1% | 1% | 5 |
6 | ANTI-CANCER DRUG DESIGN | 1775 | 1% | 1% | 4 |
7 | INORGANICA CHIMICA ACTA | 909 | 3% | 0% | 15 |
8 | CANCER TREATMENT REVIEWS | 891 | 1% | 0% | 5 |
9 | MONATSHEFTE FUR CHEMIE | 716 | 2% | 0% | 8 |
10 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 614 | 2% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GUST, R , BECK, W , JAOUEN, G , SCHONENBERGER, H , (2009) OPTIMIZATION OF CISPLATIN FOR THE TREATMENT OF HORMONE-DEPENDENT TUMORAL DISEASES PART 2: USE OF NON-STEROIDAL LIGANDS.COORDINATION CHEMISTRY REVIEWS. VOL. 253. ISSUE 21-22. P. 2760-2779 | 93 | 82% | 22 |
2 | GUST, R , BECK, W , JAOUEN, G , SCHONENBERGER, H , (2009) OPTIMIZATION OF CISPLATIN FOR THE TREATMENT OF HORMONE DEPENDENT TUMORAL DISEASES PART 1: USE OF STEROIDAL LIGANDS.COORDINATION CHEMISTRY REVIEWS. VOL. 253. ISSUE 21-22. P. 2742 -2759 | 52 | 42% | 44 |
3 | GUST, R , NIEBLER, K , SCHONENBERGER, H , (2005) [N-ETHYL- AND [N,N '-DIETHYL-1,2-BIS(2,6-DIFLUORO-3-HYDROXYPHENYL)-ETHYLENEDIAMINE]DICHLOROPLATINUM(II): STRUCTURE AND CYTOTOXIC/ESTROGENIC ACTIVITY IN BREAST CANCER CELLS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 48. ISSUE 23. P. 7132 -7144 | 26 | 65% | 7 |
4 | SCHERTL, S , HARTMANN, RW , BATZL-HARTMANN, C , SCHLEMMER, R , SPRUSS, T , BERNHARDT, G , GUST, R , SCHONENBERGER, H , (2001) 1-(2,6-DICHLORO-4-HYDROXYPHENYL)-2-PHENYLETHANES - NEW BIOLOGICAL RESPONSE MODIFIERS FOR THE THERAPY OF BREAST CANCER. SYNTHESIS AND EVALUATION OF ESTROGENIC/ANTIESTROGENIC PROPERTIES.ARCHIV DER PHARMAZIE. VOL. 334. ISSUE 4. P. 125-137 | 17 | 100% | 4 |
5 | SCHLEMMER, R , SPRUSS, T , BERNHARDT, G , SCHONENBERGER, H , (1999) [MESO-1,2-BIS(2,6-DICHLORO-4-HYDROXYPHENYL)ETHYLENEDIAMINE]DICHLOROPLATINUM(II), A COMPOUND WITH A SPECIFIC ACTIVITY ON HORMONE-SENSITIVE BREAST CANCERS - EVIDENCE FOR A DIETHYLSTILBESTROL-LIKE MODE OF ACTION.ARCHIV DER PHARMAZIE. VOL. 332. ISSUE 2. P. 59-69 | 22 | 79% | 7 |
6 | SCHERTL, S , HARTMANN, RW , BATZL-HARTMANN, C , BERNHARDT, G , SPRUSS, T , BECKENLEHNER, K , KOCH, M , KRAUSER, R , SCHLEMMER, R , GUST, R , ET AL (2004) [1,2-BIS(2,6-DIFLUORO-3-HYDROXYPHENYL)ETHYLENEDIAMINE]PLATINUM(II) COMPLEXES, COMPOUNDS FOR THE ENDOCRINE THERAPY OF BREAST CANCER - MODE OF ACTION I: ANTITUMOR ACTIVITY DUE TO THE REDUCTION OF THE ENDOGENOUS ESTROGEN LEVEL.ARCHIV DER PHARMAZIE. VOL. 337. ISSUE 6. P. 335-348 | 24 | 56% | 10 |
7 | DOLOTOVA, O , KALIYA, OL , (2011) DEVELOPMENT OF THE SYNTHESIS OF THE DIAMINE COMPLEXES OF COVALENT CONJUGATES OF PLATINUM(II) WITH OCTACARBOXY-SUBSTITUTED COBALT PHTHALOCYANINE.JOURNAL OF PORPHYRINS AND PHTHALOCYANINES. VOL. 15. ISSUE 7-8. P. 632 -638 | 13 | 81% | 5 |
8 | WURTENBERGER, I , ANGERRNAIER, B , KIRCHER, B , GUST, R , (2013) SYNTHESIS AND IN VITRO PHARMACOLOGICAL BEHAVIOR OF PLATINUM(II) COMPLEXES CONTAINING 1,2-DIAMINO-1-(4-FLUOROPHENYL)-2-ALKANOL LIGANDS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 56. ISSUE 20. P. 7951-7964 | 16 | 59% | 7 |
9 | KAMMERMEIER, T , WIEGREBE, W , (1995) 1,3-DIPHENYLPROPANE-1,3-DIAMINES .5. DNA-INTERACTION, ESTROGEN-RECEPTOR AFFINITY, AND CYTOSTATIC ACTIVITY OF 1,3-DIPHENYLPROPANE-1,3-DIAMINE-PT(II) COMPLEXES.ARCHIV DER PHARMAZIE. VOL. 328. ISSUE 5. P. 409-415 | 24 | 65% | 8 |
10 | GUST, R , FADERL, M , SCHONENBERGER, H , (2000) [AQUA-1-(2,6-DICHLORO-4-HYDROXYPHENYL)-2-PHENYLETHYLENEDIAMINE] SULFATOPLATINUM(II) COMPLEXES WITH VARIABLE SUBSTITUENTS IN THE 2-PHENYL RING - 3. INVESTIGATION OF BREAST CANCER INHIBITING PROPERTIES.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. VOL. 126. ISSUE 11. P. 647-654 | 13 | 100% | 6 |
Classes with closest relation at Level 1 |